Kyung Nam Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	-	50,814	25,960	42,992	22,931	22,728
Short-Term Investments	-	-	0	500	0	-
Trading Asset Securities	-	-	9,053	1,985	316.23	4,766
Cash & Short-Term Investments	-	50,814	35,013	45,478	23,248	27,495
Cash Growth	-	45.13%	-23.01%	95.62%	-15.45%	14.86%
Accounts Receivable	-	14,124	18,321	13,753	16,063	19,536
Other Receivables	-	62.98	602.48	116.91	337.14	82.16
Receivables	-	14,187	19,314	13,870	16,451	19,670
Inventory	-	12,215	13,478	12,611	13,979	9,664
Prepaid Expenses	-	125.14	508.29	1,050	976.54	157
Other Current Assets	-	484.01	985.2	1,729	265.91	653.05
Total Current Assets	-	77,825	69,298	74,738	54,920	57,639
Property, Plant & Equipment	-	32,327	46,710	31,235	33,852	32,227
Long-Term Investments	-	16,560	5,426	-	-	-
Goodwill	-	-	4,190	-	139.69	139.69
Other Intangible Assets	-	368.38	5,454	804.76	924.01	620.12
Long-Term Accounts Receivable	-	-0	0	-0	-0	0
Long-Term Deferred Tax Assets	-	135.03	881.21	1,922	7,530	7,678
Other Long-Term Assets	-	39,369	34,650	29,568	27,940	28,352
Total Assets	-	166,584	166,609	138,269	125,307	126,655

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Accounts Payable	-	5,557	7,242	3,366	4,430	6,341
Accrued Expenses	-	755.58	1,134	532.96	566.29	805.93
Short-Term Debt	-	9,396	17,497	8,776	11,415	11,618
Current Portion of Long-Term Debt	-	24,000	24,185	24,000	1,800	1,800
Current Portion of Leases	-	115.62	563.48	220.1	342.5	296.41
Current Income Taxes Payable	-	1.69	56.76	0.86	0.77	-
Current Unearned Revenue	-	-	215.02	-	-	-
Other Current Liabilities	-	6,453	16,039	7,051	6,857	17,744
Total Current Liabilities	-	46,279	66,933	43,947	25,411	38,605
Long-Term Debt	-	4,000	8,760	-	25,650	27,450
Long-Term Leases	-	74.87	324.71	197.08	308.13	228.1
Pension & Post-Retirement Benefits	-	633.78	-	-	816.02	2,172
Other Long-Term Liabilities	-	373.11	759.43	354.33	592.33	836.36
Total Liabilities	-	51,361	76,777	44,498	52,778	69,291

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Common Stock	-	7,815	17,797	16,740	10,025	8,721
Additional Paid-In Capital	-	141,835	104,275	98,061	72,237	56,009
Retained Earnings	-	-36,570	-45,041	-23,102	-11,506	-9,173
Treasury Stock	-	-1.08	-1.08	-1.08	-1.08	-1.08
Comprehensive Income & Other	-	2,144	2,332	2,074	1,774	1,807
Total Common Equity	-	115,223	79,362	93,771	72,529	57,364
Minority Interest	-	-	10,471	-	-	-
Shareholders' Equity	-	115,223	89,832	93,771	72,529	57,364
Total Liabilities & Equity	-	166,584	166,609	138,269	125,307	126,655

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Total Debt	-	37,587	51,330	33,193	39,515	41,392
Net Cash (Debt)	-	13,228	-16,318	12,285	-16,268	-13,898
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-	1521.69	-2301.43	2105.17	-3560.18	-4028.82
Filing Date Shares Outstanding	15.61	15.63	7.12	6.7	4.01	3.49
Total Common Shares Outstanding	15.61	15.63	7.12	6.7	4.01	3.49
Working Capital	-	31,546	2,365	30,792	29,509	19,035
Book Value Per Share	-	7372.20	11148.44	14004.22	18087.67	16443.90
Tangible Book Value	-	114,855	69,717	92,966	71,465	56,604
Tangible Book Value Per Share	-	7348.63	9793.63	13884.03	17822.40	16226.09
Land	-	20,049	27,988	17,715	15,707	15,707
Buildings	-	11,337	13,013	10,979	9,860	9,754
Machinery	-	10,049	13,168	10,648	10,553	7,733
Construction In Progress	-	184.45	888.2	164.4	4,974	6,379